Evidence map›Paper›PMID 41145490›Full record

ArticleNature communications2025

Endothelial RNF20 suppresses endothelial-to-mesenchymal transition and safeguards physiological angiocrine signaling to prevent congenital heart disease.

Yanliang Dou, Nalan Tetik-Elsherbiny, Rui Gao, Yonggang Ren, Yu-Wen Chen, Moritz Merbecks, Aadhyaa Setya, Olga Lityagina, Yinuo Wang, Evgeny Chichelnitskiy and 12 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Decoding RNF20: an epigenetic modifier and beyond.Frontiers in cell and developmental biology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Yanliang Dou *Department of Cardiovascular Genomics and Epigenomics, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Nalan Tetik-Elsherbiny *Department of Cardiovascular Genomics and Epigenomics, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID http://orcid.org/0009-0005-6537-6783
Rui Gao *Department of Cardiovascular Genomics and Epigenomics, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID http://orcid.org/0009-0006-1400-4637
Yonggang RenDepartment of Cardiovascular Genomics and Epigenomics, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Yu-Wen ChenDepartment of Cardiovascular Genomics and Epigenomics, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Moritz MerbecksDepartment of Pediatric and Congenital Cardiology, University Hospital Heidelberg, Heidelberg, Germany.
Aadhyaa SetyaDepartment of Cardiovascular Genomics and Epigenomics, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Olga LityaginaDepartment of Cardiovascular Genomics and Epigenomics, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Yinuo WangDepartment of Cardiovascular Genomics and Epigenomics, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID http://orcid.org/0000-0002-6653-6014
Evgeny ChichelnitskiyMax Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
Aya AbouissaDepartment of Cardiovascular Physiology, ECAS, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID http://orcid.org/0000-0002-8325-0296
Chi-Chung WuPloidy and Organ Physiology Laboratory, ECAS, Heidelberg University, Mannheim, Germany.
Guillermo BarretoUniversité de Lorraine, CNRS, Laboratoire IMoPA, UMR 7365, Nancy, France.ORCID http://orcid.org/0000-0002-7777-4712
Michael PotenteBerlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0002-5689-0036
Thomas WielandGerman Centre for Cardiovascular Research (DZHK), Mannheim, Germany.ORCID http://orcid.org/0000-0001-8262-8261
Roxana OlaCardiovascular Pharmacology, ECAS, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID http://orcid.org/0000-0002-2566-4431
Philippe GrieshaberDivision of Pediatric Cardiac Surgery, Department of Cardiac Surgery, University Hospital Heidelberg, Heidelberg, Germany.
Tsvetomir LoukanovDivision of Pediatric Cardiac Surgery, Department of Cardiac Surgery, University Hospital Heidelberg, Heidelberg, Germany.
Matthias GorenfloDepartment of Pediatric and Congenital Cardiology, University Hospital Heidelberg, Heidelberg, Germany.
Joerg HeinekeDepartment of Cardiovascular Physiology, ECAS, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID http://orcid.org/0000-0002-1541-3030
Julio CorderoDepartment of Cardiovascular Genomics and Epigenomics, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. Julio.Cordero@medma.uni-heidelberg.de.ORCID http://orcid.org/0000-0002-2136-1783
Gergana DobrevaDepartment of Cardiovascular Genomics and Epigenomics, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. Gergana.Dobreva@medma.uni-heidelberg.de.ORCID http://orcid.org/0000-0002-4814-9416

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) CRC 1366 (Projects A03)Deutsche Forschungsgemeinschaft (German Research Foundation) CRC1550 (Project A03)
6 · The paper itself

Abstract

Heart morphogenesis and function rely on intricate communication among distinct cardiac cell types. How their co-development and crosstalk are coordinated is largely unexplored. Our study unveils key functions of the histone H2B ubiquitin (H2Bub1) ligase RNF20 in second heart field development and cardiac endothelial cells. We demonstrate that RNF20 promotes Nrg1 expression through a RNF20-H2Bub1-dependent mechanism and restrains TGF-β signaling by influencing RNA polymerase II pause release at TGF-β target genes in endothelial cells. While heightened TGF-β signaling following RNF20 loss results endothelial-to-mesenchymal transition (EndMT), both impaired Nrg1 signaling and elevated TGF-β activity contribute to abnormal cardiomyocyte proliferation and contractility. Importantly, RNF20 expression is significantly reduced in cardiac endothelial cells from congenital heart disease patients showing a positive correlation with oxygen saturation and a negative correlation with key components and downstream effectors of TGF-β signaling. In summary, our work identifies a crucial role for RNF20 in safeguarding endothelial identity and physiological angiocrine signaling, thereby ensuring proper heart development and function.

Indexed as

Endothelial CellsEpithelial-Mesenchymal TransitionHeart Defects, CongenitalUbiquitin-Protein LigasesAnimalsCell ProliferationHeartHumansMaleMiceMyocytes, CardiacSignal TransductionTransforming Growth Factor betaTransforming Growth Factor betaUbiquitin-Protein Ligases

Identifiers

PMID41145490
PMCPMC12559710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.